Chicago Partners Investment Group LLC Legend Biotech Corp Transaction History

Chicago Partners Investment Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$39.5 - $57.22 $10,112 - $14,648	-256 Reduced 5.1%	4,762 $210,000
Q1 2024 Apr 25, 2024	BUY	$55.06 - $69.99 $44,103 - $56,061	801 Added 18.99%	5,018 $281,000
Q4 2023 Feb 23, 2024	SELL	$57.25 - $69.74 $41,105 - $50,073	-718 Reduced 14.55%	4,217 $253,000
Q3 2023 Oct 26, 2023	BUY	$63.16 - $76.5 $311,694 - $377,527	4,935 New	4,935 $331,000

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.